α-Synuclein and Parkinson's disease: Selective neurodegenerative effect of α-synuclein fragment on dopaminergic neurons in vitro and in vivo

Gianluigi Forloni, Ilaria Bertani, Anna Maria Calella, Florian Thaler, Roberto Invernizzi

Research output: Contribution to journalArticle

Abstract

Missense mutations in the α-synuclein gene were associated with a familial Parkinson's disease, and α-synuclein is a major component of Lewy bodies, the intracellular inclusions that neuropathologically characterize Parkinson's disease. We investigated the neurotoxic activity of the nonamyloid component (NAC) of senile plaque, the fibrillogenic fragment (61- 95) of α-synuclein, in vitro and in vivo. Rat primary mesencephalic neurons were exposed for 6 days to low concentrations of preaggregated NAC (0.5-10.0 μM). The number of dopaminergic neurons and dopamine content were both reduced with no effect on the general viability of the cells. At higher concentrations (25-100 μM), the neurotoxic effect of NAC was extended to all neurons. Preaggregated NAC was also toxic on a PC12 dopaminergic cell line differentiated with nerve growth factor. The intracellular localization of NAC has been identified by the exposure of neuronal cells to fluorescent peptide. In vivo application of aggregated NAC in the substantia nigra induced loss of dopaminergic neurons. Our data illustrate the selective neurotoxic effect of NAC for dopaminergic neurons and support the central role of α-synuclein in the pathogenesis of Parkinson's disease.

Original languageEnglish
Pages (from-to)632-640
Number of pages9
JournalAnnals of Neurology
Volume47
Issue number5
DOIs
Publication statusPublished - 2000

Fingerprint

Synucleins
Dopaminergic Neurons
Parkinson Disease
Lewy Bodies
Neurons
Poisons
PC12 Cells
Amyloid Plaques
Nerve Growth Factor
Substantia Nigra
Missense Mutation
Dopamine
Cell Survival
Cell Line
Peptides
In Vitro Techniques
Genes

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

α-Synuclein and Parkinson's disease : Selective neurodegenerative effect of α-synuclein fragment on dopaminergic neurons in vitro and in vivo. / Forloni, Gianluigi; Bertani, Ilaria; Calella, Anna Maria; Thaler, Florian; Invernizzi, Roberto.

In: Annals of Neurology, Vol. 47, No. 5, 2000, p. 632-640.

Research output: Contribution to journalArticle

@article{3b72d1f9f4844c2b8b0d4d5d5a7798cb,
title = "α-Synuclein and Parkinson's disease: Selective neurodegenerative effect of α-synuclein fragment on dopaminergic neurons in vitro and in vivo",
abstract = "Missense mutations in the α-synuclein gene were associated with a familial Parkinson's disease, and α-synuclein is a major component of Lewy bodies, the intracellular inclusions that neuropathologically characterize Parkinson's disease. We investigated the neurotoxic activity of the nonamyloid component (NAC) of senile plaque, the fibrillogenic fragment (61- 95) of α-synuclein, in vitro and in vivo. Rat primary mesencephalic neurons were exposed for 6 days to low concentrations of preaggregated NAC (0.5-10.0 μM). The number of dopaminergic neurons and dopamine content were both reduced with no effect on the general viability of the cells. At higher concentrations (25-100 μM), the neurotoxic effect of NAC was extended to all neurons. Preaggregated NAC was also toxic on a PC12 dopaminergic cell line differentiated with nerve growth factor. The intracellular localization of NAC has been identified by the exposure of neuronal cells to fluorescent peptide. In vivo application of aggregated NAC in the substantia nigra induced loss of dopaminergic neurons. Our data illustrate the selective neurotoxic effect of NAC for dopaminergic neurons and support the central role of α-synuclein in the pathogenesis of Parkinson's disease.",
author = "Gianluigi Forloni and Ilaria Bertani and Calella, {Anna Maria} and Florian Thaler and Roberto Invernizzi",
year = "2000",
doi = "10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.0.CO;2-N",
language = "English",
volume = "47",
pages = "632--640",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - α-Synuclein and Parkinson's disease

T2 - Selective neurodegenerative effect of α-synuclein fragment on dopaminergic neurons in vitro and in vivo

AU - Forloni, Gianluigi

AU - Bertani, Ilaria

AU - Calella, Anna Maria

AU - Thaler, Florian

AU - Invernizzi, Roberto

PY - 2000

Y1 - 2000

N2 - Missense mutations in the α-synuclein gene were associated with a familial Parkinson's disease, and α-synuclein is a major component of Lewy bodies, the intracellular inclusions that neuropathologically characterize Parkinson's disease. We investigated the neurotoxic activity of the nonamyloid component (NAC) of senile plaque, the fibrillogenic fragment (61- 95) of α-synuclein, in vitro and in vivo. Rat primary mesencephalic neurons were exposed for 6 days to low concentrations of preaggregated NAC (0.5-10.0 μM). The number of dopaminergic neurons and dopamine content were both reduced with no effect on the general viability of the cells. At higher concentrations (25-100 μM), the neurotoxic effect of NAC was extended to all neurons. Preaggregated NAC was also toxic on a PC12 dopaminergic cell line differentiated with nerve growth factor. The intracellular localization of NAC has been identified by the exposure of neuronal cells to fluorescent peptide. In vivo application of aggregated NAC in the substantia nigra induced loss of dopaminergic neurons. Our data illustrate the selective neurotoxic effect of NAC for dopaminergic neurons and support the central role of α-synuclein in the pathogenesis of Parkinson's disease.

AB - Missense mutations in the α-synuclein gene were associated with a familial Parkinson's disease, and α-synuclein is a major component of Lewy bodies, the intracellular inclusions that neuropathologically characterize Parkinson's disease. We investigated the neurotoxic activity of the nonamyloid component (NAC) of senile plaque, the fibrillogenic fragment (61- 95) of α-synuclein, in vitro and in vivo. Rat primary mesencephalic neurons were exposed for 6 days to low concentrations of preaggregated NAC (0.5-10.0 μM). The number of dopaminergic neurons and dopamine content were both reduced with no effect on the general viability of the cells. At higher concentrations (25-100 μM), the neurotoxic effect of NAC was extended to all neurons. Preaggregated NAC was also toxic on a PC12 dopaminergic cell line differentiated with nerve growth factor. The intracellular localization of NAC has been identified by the exposure of neuronal cells to fluorescent peptide. In vivo application of aggregated NAC in the substantia nigra induced loss of dopaminergic neurons. Our data illustrate the selective neurotoxic effect of NAC for dopaminergic neurons and support the central role of α-synuclein in the pathogenesis of Parkinson's disease.

UR - http://www.scopus.com/inward/record.url?scp=0034017710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034017710&partnerID=8YFLogxK

U2 - 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.0.CO;2-N

DO - 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.0.CO;2-N

M3 - Article

C2 - 10805334

AN - SCOPUS:0034017710

VL - 47

SP - 632

EP - 640

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 5

ER -